| Lee, Bong-Ki |
| Active, not recruiting | 4 | 2018 | RoW | Tailored antithrombotic strategy, Conventional antithrombotic strategy | Duk-Woo Park, MD, CardioVascular Research Foundation, Korea | Coronary Stenoses | 01/25 | 01/25 | | |
ASSURE-DES, NCT02797548: Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent Undergoing Noncardiac Surgery |
|
|
| Completed | 4 | 1010 | RoW | Aspirin only, No antiplatelet therapy | Jung-min Ahn, CardioVascular Research Foundation, Korea | Antiplatelet Drugs | 05/24 | 05/24 | | |
PROTECT-HBR, NCT04416581: Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy |
|
|
| Recruiting | 4 | 3100 | RoW | PPI, P-CAB 50 | Duk-Woo Park, MD | Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome, Myocardial Infarction | 09/26 | 12/27 | | |
DCB-SFA, NCT02648334: Randomized Comparison of DCB for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease |
|
|
| Completed | N/A | 443 | RoW | IN.PACT drug coated balloon, Lutonix drug coated balloon | Seung-Whan Lee, M.D., Ph.D. | Angioplasty, Balloon, Catheterization, Peripheral, Popliteal Artery, Femoral Artery | 01/23 | 08/24 | | |
NCT03611725: Comparison of Success Rate Between Distal Radial Approach and Radial Approach in STEMI |
|
|
| Completed | N/A | 352 | RoW | Distal radial artery, Radial artery | Wonju Severance Christian Hospital, Hanmi Pharmaceutical co., ltd. | Distal Radial Artery Approach, ST Elevation Myocardial Infarction | 03/23 | 12/23 | | |
| Active, not recruiting | N/A | 2000 | RoW | Xience Sierra stent | Seung-Jung Park, CardioVascular Research Foundation, Korea | Coronary Artery Disease, Coronary Disease | 07/24 | 12/28 | | |
| Recruiting | N/A | 4500 | RoW | Onyx Drug Eluting Stent group | Seung-Jung Park, CardioVascular Research Foundation, Korea, Medtronic Korea Co., Ltd. | Coronary Artery Disease, Arterial Occlusive Diseases, Cardiovascular Diseases, Percutaneous Transluminal Angioplasty | 12/25 | 12/29 | | |
| Recruiting | N/A | 1000 | RoW | 5 year Follow-up | Seung-Jung Park, CardioVascular Research Foundation, Korea | Percutaneous Transluminal Coronary Angioplasty | 06/24 | 12/27 | | |
| Recruiting | N/A | 2000 | RoW | Ultimaster™ Tansei™ stents | Duk-Woo Park, MD, CardioVascular Research Foundation, Korea | Coronary Artery Disease | 09/24 | 12/28 | | |
| Recruiting | N/A | 1000 | RoW | BIOFREEDOM™ FAMILY stent | Seung-Jung Park, CardioVascular Research Foundation, Korea | Coronary Stenosis | 12/24 | 12/29 | | |
NCT05807841: Clinical Impact of Intravascular Ultrasound-Based Artificial Intelligence Technologies (INNOVATE-PCI) |
|
|
| Recruiting | N/A | 3000 | RoW | percutaneous coronary intervention | Asan Medical Center, Boston Scientific Corporation | Coronary Artery Disease | 06/25 | 06/25 | | |
| Recruiting | N/A | 20000 | RoW | | Seung-Jung Park, CardioVascular Research Foundation, Korea, Abbott Medical Devices | Coronary Artery Disease | 04/37 | 04/37 | | |
ASSIST, NCT05529459: Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Eluting in Patients With CAD |
|
|
| Recruiting | N/A | 2400 | RoW | Percutaneous Coronary Intervention | Seung-Whan Lee, M.D., Ph.D., Biotronik Korea Co., Ltd | Coronary Disease | 12/26 | 07/30 | | |
PROVE-DM, NCT05579626: Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus |
|
|
| Recruiting | N/A | 4000 | RoW | high-intensity statin arm, low-intensity statin plus ezetimibe | Seung-Whan Lee, M.D., Ph.D., Yuhan Corporation | Pre Diabetes, ASCVD | 12/27 | 12/27 | | |
STRIKE-CTO, NCT03667196: Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of Percutaneous Coronary Intervention for Chronic Total Occlusions |
|
|
| Recruiting | N/A | 4000 | RoW | antegrade and retrograde approach | Seung-Whan Lee, M.D., Ph.D., Abbott Medical Devices, Biotronik SE & Co. KG, Medtronic, Dio Medical | Chronic Total Occlusion of Coronary Artery | 12/27 | 12/27 | | |
| Recruiting | N/A | 1000 | RoW | computed tomography perfusion guided treatment, Fractional flow reserve guided treatment | Young-Hak Kim, MD, PhD | Coronary Disease | 03/28 | 03/28 | | |
| Bae, Jae Moon |
| Recruiting | 4 | 3944 | RoW | aspirin, clopidogrel, prasugrel, ticagrelor | Asan Medical Center | Coronary Artery Disease | 08/27 | 12/28 | | |
ASSIST, NCT05529459: Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Eluting in Patients With CAD |
|
|
| Recruiting | N/A | 2400 | RoW | Percutaneous Coronary Intervention | Seung-Whan Lee, M.D., Ph.D., Biotronik Korea Co., Ltd | Coronary Disease | 12/26 | 07/30 | | |
PROVE-DM, NCT05579626: Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus |
|
|
| Recruiting | N/A | 4000 | RoW | high-intensity statin arm, low-intensity statin plus ezetimibe | Seung-Whan Lee, M.D., Ph.D., Yuhan Corporation | Pre Diabetes, ASCVD | 12/27 | 12/27 | | |
STRIKE-CTO, NCT03667196: Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of Percutaneous Coronary Intervention for Chronic Total Occlusions |
|
|
| Recruiting | N/A | 4000 | RoW | antegrade and retrograde approach | Seung-Whan Lee, M.D., Ph.D., Abbott Medical Devices, Biotronik SE & Co. KG, Medtronic, Dio Medical | Chronic Total Occlusion of Coronary Artery | 12/27 | 12/27 | | |
| Choi, Daehee |
Cellgram-LC, NCT04689152: Clinical Trial to Evaluate the Efficacy and Safety of Administration in Patients With Alcoholic Cirrhosis |
|
|
| Recruiting | 3 | 200 | RoW | Cellgram-LC, Autologous bone marrow-derived mesenchymal stem cell | Pharmicell Co., Ltd. | Alcoholic Cirrhosis | 08/27 | 01/28 | | |
NCT05093881: Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study |
|
|
| Recruiting | N/A | 100 | RoW | Cellgram-LC | Pharmicell Co., Ltd. | Alcoholic Cirrhosis | 08/26 | 03/28 | | |
| Seo, Young-Hoon |
PROVE-DM, NCT05579626: Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus |
|
|
| Recruiting | N/A | 4000 | RoW | high-intensity statin arm, low-intensity statin plus ezetimibe | Seung-Whan Lee, M.D., Ph.D., Yuhan Corporation | Pre Diabetes, ASCVD | 12/27 | 12/27 | | |
